DarioHealth Corp. (DRIO) earnings
DRIO earnings moved a median of -1.49% by the close. Quarterly and annual DRIO reports and results, each read against the price at its own news timestamp. Back to the DRIO overview →
31 measured DRIO earnings events.
Where these DRIO earnings landedvs 27 measured DRIO earnings reactions
| Middle 50% of DRIO earnings reactions | -5.00% to +4.50% |
|---|---|
| Median reaction (to close) | -1.49% |
| Measured reactions | 27 |
Point-in-time · zero look-ahead
Half of the 27 DRIO earnings events with a measured close landed between -5.00% and +4.50%; 44% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| DarioHealth Reports Second Quarter 2026 Financial Results | Press release | -3.27% | +4.50% | |
| Form 10-Q DarioHealth Corp. For: Jun 30 | SEC filing · Form 10-Q | -3.27% | +4.50% | |
| DarioHealth to Report Second Quarter 2026 Results on Tuesday, August 11, 2026 | Press release | — | -2.20% | |
| DarioHealth Reports First Quarter 2026 Financial and Operating Results | Press release | — | -5.26% | |
| Form 10-Q DarioHealth Corp. For: Mar 31 | SEC filing · Form 10-Q | — | -5.26% | |
| DarioHealth to Report First Quarter 2026 Results on Wednesday, May 13, 2026 | Press release | — | +4.34% | |
| Form 10-K DarioHealth Corp. For: Dec 31 | SEC filing · Form 10-K | -5.87% | -12.06% | |
| DarioHealth Reports Third Quarter 2025 Financial and Operating Results | Press release | -12.09% | — | |
| Form 10-Q DarioHealth Corp. For: Sep 30 | SEC filing · Form 10-Q | -12.09% | — | |
| DarioHealth to Report Third Quarter 2025 Results on Thursday, November 13, 2025 | Press release | +0.00% | -9.45% | |
| DarioHealth Reports Second Quarter 2025 Financial and Operating Results | Press release | +2.50% | — | |
| Form 10-Q DarioHealth Corp. For: Jun 30 | SEC filing · Form 10-Q | +2.50% | — | |
| DarioHealth to Report Second Quarter 2025 Results on Tuesday, August 12, 2025 | Press release | +0.00% | -3.62% | |
| DarioHealth Reports First Quarter 2025 Financial and Operating Results | Press release | -0.58% | -1.49% | |
| Form 10-Q DarioHealth Corp. For: Mar 31 | SEC filing · Form 10-Q | -0.58% | -1.49% | |
| DarioHealth to Report First Quarter 2025 Results on Wednesday, May 14, 2025 | Press release | -1.83% | -4.74% | |
| Form 10-K DarioHealth Corp. For: Dec 31 | SEC filing · Form 10-K | -9.09% | -12.86% | |
| DarioHealth Reports Third Quarter 2024 Financial and Operating Results | Press release | -5.00% | -2.98% | |
| Form 10-Q DarioHealth Corp. For: Sep 30 | SEC filing · Form 10-Q | -5.00% | -2.98% | |
| DarioHealth to Report Third Quarter 2024 Results on Thursday, November 7th | Press release | +1.07% | +0.00% | |
| DarioHealth Reports Second Quarter 2024 Financial and Operating Results | Press release | -4.83% | -15.64% | |
| Form 10-Q DarioHealth Corp. For: Jun 30 | SEC filing · Form 10-Q | -4.83% | -15.64% | |
| DarioHealth to Report Second Quarter 2024 Results on Thursday, August 8th | Press release | -0.43% | +0.86% | |
| DarioHealth Reports First Quarter 2024 Financial and Operating Results | Press release | -0.61% | +12.80% | |
| Form 10-Q DarioHealth Corp. For: Mar 31 | SEC filing · Form 10-Q | -0.61% | +12.80% | |
| DarioHealth to Report First Quarter 2024 Results on Wednesday, May 15th | Press release | +0.00% | +1.24% | |
| Form 10-K DarioHealth Corp. For: Dec 31 | SEC filing · Form 10-K | +2.76% | +5.52% | |
| DARIOHEALTH TO REPORT FOURTH QUARTER 2023 RESULTS ON THURSDAY, MARCH 28TH | Press release | -0.69% | +0.69% | |
| DarioHealth Reports Third Quarter 2023 Financial and Operating Results | Press release | -3.69% | +36.49% | |
| Form 10-Q DarioHealth Corp. For: Sep 30 | SEC filing · Form 10-Q | -3.69% | +36.49% | |
| DarioHealth to Report Third Quarter 2023 Results on Thursday, November 2nd | Press release | +1.50% | +4.51% |
Keep exploring
More DRIO: analyst actions → · SEC filings → · DRIO overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Editas Medicine, Inc. (EDIT) | 253 | -1.15% | 39% |
| Nevro Corp. (NVRO) | 253 | 0.00% | 49% |
| Cue Biopharma, Inc. (CUE) | 251 | -0.05% | 50% |
| DOVA PHARMACEUTICALS (DOVA) | 251 | -0.10% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.